Paulet E, Contreras V, Galhaut M, Rosenkrands I, Holland M, Burton M
PLoS Negl Trop Dis. 2024; 18(8):e0012388.
PMID: 39093884
PMC: 11333008.
DOI: 10.1371/journal.pntd.0012388.
Pagliarani S, Johnston S, Beagley K, Palmieri C
Vet Pathol. 2024; 61(4):621-632.
PMID: 38240274
PMC: 11264539.
DOI: 10.1177/03009858231225499.
Ageed A, Khan M
Cureus. 2024; 16(1):e52358.
PMID: 38234389
PMC: 10792353.
DOI: 10.7759/cureus.52358.
Olsen A, Rosenkrands I, Holland M, Andersen P, Follmann F
NPJ Vaccines. 2021; 6(1):58.
PMID: 33875654
PMC: 8055873.
DOI: 10.1038/s41541-021-00312-9.
Pinsent A, Gambhir M
PLoS Negl Trop Dis. 2017; 11(2):e0005378.
PMID: 28182664
PMC: 5321453.
DOI: 10.1371/journal.pntd.0005378.
The Relationship between Active Trachoma and Ocular Chlamydia trachomatis Infection before and after Mass Antibiotic Treatment.
Ramadhani A, Derrick T, Macleod D, Holland M, Burton M
PLoS Negl Trop Dis. 2016; 10(10):e0005080.
PMID: 27783678
PMC: 5082620.
DOI: 10.1371/journal.pntd.0005080.
Control of trachoma in Australia: a model based evaluation of current interventions.
Shattock A, Gambhir M, Taylor H, Cowling C, Kaldor J, Wilson D
PLoS Negl Trop Dis. 2015; 9(4):e0003474.
PMID: 25860143
PMC: 4393231.
DOI: 10.1371/journal.pntd.0003474.
The Role of the Immune Response in Chlamydia trachomatis Infection of the Male Genital Tract: A Double-Edged Sword.
Redgrove K, McLaughlin E
Front Immunol. 2014; 5:534.
PMID: 25386180
PMC: 4209867.
DOI: 10.3389/fimmu.2014.00534.
Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research.
Vasilevsky S, Greub G, Nardelli-Haefliger D, Baud D
Clin Microbiol Rev. 2014; 27(2):346-70.
PMID: 24696438
PMC: 3993100.
DOI: 10.1128/CMR.00105-13.
Towards a safe and effective chlamydial vaccine: lessons from the eye.
Mabey D, Hu V, Bailey R, Burton M, Holland M
Vaccine. 2014; 32(14):1572-8.
PMID: 24606636
PMC: 3991328.
DOI: 10.1016/j.vaccine.2013.10.016.
Spontaneous resolution of genital Chlamydia trachomatis infection in women and protection from reinfection.
Geisler W, Lensing S, Press C, Hook 3rd E
J Infect Dis. 2013; 207(12):1850-6.
PMID: 23470847
PMC: 3654745.
DOI: 10.1093/infdis/jit094.
Trachoma: protective and pathogenic ocular immune responses to Chlamydia trachomatis.
Hu V, Holland M, Burton M
PLoS Negl Trop Dis. 2013; 7(2):e2020.
PMID: 23457650
PMC: 3573101.
DOI: 10.1371/journal.pntd.0002020.
Targeting antibiotics to households for trachoma control.
Blake I, Burton M, Solomon A, West S, Basanez M, Gambhir M
PLoS Negl Trop Dis. 2010; 4(11):e862.
PMID: 21072225
PMC: 2970531.
DOI: 10.1371/journal.pntd.0000862.
In vivo confocal microscopy of trachoma in relation to normal tarsal conjunctiva.
Hu V, Massae P, Weiss H, Cree I, Courtright P, Mabey D
Ophthalmology. 2010; 118(4):747-54.
PMID: 21055819
PMC: 3267042.
DOI: 10.1016/j.ophtha.2010.08.029.
Immunobiological outcomes of repeated chlamydial infection from two models of within-host population dynamics.
Vickers D, Zhang Q, Osgood N
PLoS One. 2009; 4(9):e6886.
PMID: 19727394
PMC: 2731222.
DOI: 10.1371/journal.pone.0006886.
The natural history of trachoma infection and disease in a Gambian cohort with frequent follow-up.
Grassly N, Ward M, Ferris S, Mabey D, Bailey R
PLoS Negl Trop Dis. 2008; 2(12):e341.
PMID: 19048024
PMC: 2584235.
DOI: 10.1371/journal.pntd.0000341.
Immune Protection Against Chlamydia trachomatis in Females.
Morrison R
Infect Dis Obstet Gynecol. 1996; 4(3):163-70.
PMID: 18476089
PMC: 2364487.
DOI: 10.1155/S106474499600035X.
Conjunctival FOXP3 expression in trachoma: do regulatory T cells have a role in human ocular Chlamydia trachomatis infection?.
Faal N, Bailey R, Jeffries D, Joof H, Sarr I, Laye M
PLoS Med. 2006; 3(8):e266.
PMID: 16881731
PMC: 1526769.
DOI: 10.1371/journal.pmed.0030266.
Fc receptor regulation of protective immunity against Chlamydia trachomatis.
Moore T, Ananaba G, Bolier J, Bowers S, Belay T, Eko F
Immunology. 2002; 105(2):213-21.
PMID: 11872097
PMC: 1782645.
DOI: 10.1046/j.0019-2805.2001.01354.x.
Resolution of secondary Chlamydia trachomatis genital tract infection in immune mice with depletion of both CD4+ and CD8+ T cells.
Morrison S, Morrison R
Infect Immun. 2001; 69(4):2643-9.
PMID: 11254630
PMC: 98202.
DOI: 10.1128/IAI.69.4.2643-2649.2001.
